Biotech Company in China required our scientific expertise for the Tech Transfer of IFE Reflex Assay on a clinical trial in the Oncology field (Relapsed or Refractory Multiple Myeloma). Cerba Research was not the Biotech’s central or specialty laboratory on the study but brought in for our expertise on the tech transfer.
Our competitor (a top 3 CRO) provided services for a client’s clinical trial but had no flexibility or experience in the transfer of reflex assays. As a result, Cerba Research was brought in as a third party and expert for the transfer. For this study on Relapsed or Refractory Multiple Myeloma (MM), an IFE Reflex Assay tech transfer was required. Unfortunately, there was no prior experience in the laboratory in China; thus, the tech transfer was implemented from scratch.
Discover how our scientists were able to realize this.
Reach out to our team of experts and discover how we can help you advance your clinical trialContact Us